USPTO serial 79348311
RNA SCRIPT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- CORNWELL, ANDREA B
- Law office
- TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with RNA SCRIPT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals, reagents, enzymes and kits comprising enzymes, monomers, solid media, synthesis plates, all for use in scientific research, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling and modifying genetic fragments, genotyping, gene modification, and analyzing biological systems, samples and cells, in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells other than for medical or veterinary use; chemical products for analyses in laboratories other than for medical or veterinary use; protein [raw material] | ACTIVE | — |
| 005 | Chemical reagents and enzymes for medical use, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling, modifying genetic fragments, genotyping, gene modification, and analysis of biological systems, samples and cells, in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells for medical use; stem cells for veterinary use | ACTIVE | — |
| 009 | Laboratory apparatus and instruments and apparatus and instruments for scientific use for polynucleotide synthesis, namely, DNA and RNA, as well as parts and accessories of such apparatus and instruments, namely, bottles, flasks, cartridges, vials, reaction plates, synthesis media, reaction tubes, as well as related computer hardware and software for use in the use and interfacing with apparatus and instruments for synthesizing polynucleotides; laboratory apparatus and instruments and apparatus and instruments for scientific use using or storing nucleic acid molecules, particularly for amplification, assembly or modification of genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; DNA chips; apparatus for scientific use for preservation, storage or processing of DNA chips containing information; computer hardware and computer software for use in apparatus and instruments for synthesizing polynucleotides; computer hardware and computer software for polynucleotide synthesis, namely, DNA and RNA; computer hardware and computer software for use in amplifying, assembling or modifying genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; computer hardware and computer software for use in preserving, storing or processing DNA chips containing information; biochips; DNA chips | ACTIVE | — |
| 010 | DNA and RNA testing apparatus for medical use; testing apparatus for medical use; diagnostic apparatus for medical use; analysis devices for identification of bacteria for medical use | ACTIVE | — |
| 042 | Technical evaluations concerning design (engineers' services); scientific research; technical research; biological research; chemical research; medical research; chemical analysis; chemistry services; scientific laboratory services; designing and testing synthetic DNA for scientific research purposes; polynucleotide synthesis services, namely, DNA and RNA for scientific research purposes; storing nucleic acid molecules, particularly for amplifying, assembling or modifying genetic fragments, genotyping, gene modification and analysis of biological cells, samples or systems; preserving, storing or processing DNA chips containing information; design of computers for third parties; computer development; software design; software development; research and development of new products for third parties; conducting of technical project studies; software development (design); software installation; software maintenance; updating of software; software rental; programming for computers; computer system analysis; computer system design; consultant services with respect to computer hardware design and development; digitization of documents; Software as a Service (SaaS); cloud computing; advice regarding information technology; hosting of servers; graphic arts design services; styling (industrial design); authentication of works of art; energy auditing; electronic data storage | ACTIVE | — |
| 044 | Medical services; veterinary services; skin care services (beauty and sanitary care); medical assistance; plastic surgery; hospital services; medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes; advice with respect to health; consultation with respect to pharmacy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DNA SCRIPT
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named RNA SCRIPT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 3, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 14, 2024 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 28, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 28, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 18, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 31, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 31, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 27, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 27, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 27, 2023 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 31, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 8, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 8, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 18, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 17, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 14, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 30, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 26, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 25, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |